After-hours movers: CrowdStrike gains following beat, Stitch Fix falls

After-Hours Movers:

Rigel Pharma (NASDAQ: RIGL) 21% HIGHER; reported Q4 EPS of $0.01, $0.10 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $51.3 million versus the consensus estimate of $36.52 million.

Arlo Technologies, Inc. (NYSE: ARLO) 11% HIGHER; reported Q4 EPS of ($0.04), $0.06 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $118.5 million versus the consensus estimate of $107.44 million. Arlo Technologies, Inc. sees Q1 2023 EPS of ($0.07)-($0.01), versus the consensus of ($0.07). Arlo Technologies, Inc. sees Q1 2023 revenue of $100-110 million, versus the consensus of $94.711 million.

Yext, Inc. (NYSE: YEXT) 7% LOWER; reported Q4 EPS of $0.05, $0.02 better than the analyst estimate of $0.03. Revenue for the quarter came in at $101.9 million versus the consensus estimate of $100.38 million.

CrowdStrike Holdings Inc. (NASDAQ: CRWD) 6% HIGHER; reported Q4 EPS of $0.47, $0.04 better than the analyst estimate of $0.43. Revenue for the quarter came in at $637.4 million versus the consensus estimate of $624.77 million. CrowdStrike Holdings Inc. sees Q1 2024 EPS of $0.50-$0.51, versus the consensus of $0.43. CrowdStrike Holdings Inc. sees Q1 2024 revenue of $674.9-678.2 million. CrowdStrike Holdings Inc. sees FY2024 EPS of $2.21-$2.39, versus the consensus of $2.00. CrowdStrike Holdings Inc. sees FY2024 revenue of $2.955-3.014 billion, versus the consensus of $2.96 billion.

Stitch Fix (NASDAQ: SFIX) 4% LOWER; reported Q2 EPS of ($0.58), which may not compare to the analyst estimate of ($0.34). Revenue for the quarter came in at $412.1 million versus the consensus estimate of $413.24 million. Dan Jedda to step down as CFO to pursue another opportunity: to be succeeded by David Aufderhaar, SVP of Finance, Stitch Fix effective April 3. Stitch Fix sees Q3 2023 revenue of $385-392 million, versus the consensus of $394.75 million.

Stitch Fix sees FY2023 revenue of $1.625-1.645 billion, versus the consensus of $1.65 billion. Sees FY2023 adjusted EBITDA to be between breakeven and $10 million.

US Foods (NYSE: USFD) 2% LOWER; large block of stock for sale via Morgan Stanley.

You May Also Be Interested In

• After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• ADARx Pharmaceuticals files for proposed IPO